ArticleJournal of gastrointestinal oncology2021

Pancreatic INI1-deficient undifferentiated rhabdoid carcinoma achieves complete clinical response on gemcitabine and nab-paclitaxel following immediate progression on FOLFIRINOX: a case report.

Daniel A King et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.